These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38650308)
1. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model. Butenko O; Jensen SM; Fillié-Grijpma YE; Verpalen R; Verschuuren JJ; van der Maarel SM; Huijbers MG; Plomp JJ Eur J Neurosci; 2024 Jun; 59(12):3292-3308. PubMed ID: 38650308 [TBL] [Abstract][Full Text] [Related]
2. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies. Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029 [TBL] [Abstract][Full Text] [Related]
3. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis. Huijbers MG; Plomp JJ; van Es IE; Fillié-Grijpma YE; Kamar-Al Majidi S; Ulrichts P; de Haard H; Hofman E; van der Maarel SM; Verschuuren JJ Exp Neurol; 2019 Jul; 317():133-143. PubMed ID: 30851266 [TBL] [Abstract][Full Text] [Related]
4. Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice. Cole RN; Ghazanfari N; Ngo ST; Gervásio OL; Reddel SW; Phillips WD J Physiol; 2010 Sep; 588(Pt 17):3217-29. PubMed ID: 20603331 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586 [TBL] [Abstract][Full Text] [Related]
6. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Richman DP; Nishi K; Morell SW; Chang JM; Ferns MJ; Wollmann RL; Maselli RA; Schnier J; Agius MA Arch Neurol; 2012 Apr; 69(4):453-60. PubMed ID: 22158720 [TBL] [Abstract][Full Text] [Related]
7. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395 [TBL] [Abstract][Full Text] [Related]
9. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects. Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis. Mori S; Shigemoto K Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506 [TBL] [Abstract][Full Text] [Related]
11. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure. Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188 [TBL] [Abstract][Full Text] [Related]
12. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis. Reddel SW; Morsch M; Phillips WD Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928 [TBL] [Abstract][Full Text] [Related]
14. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. Koneczny I; Cossins J; Vincent A J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718 [TBL] [Abstract][Full Text] [Related]
15. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. Koneczny I; Herbst R Cells; 2019 Jul; 8(7):. PubMed ID: 31269763 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK. Lim JL; Augustinus R; Plomp JJ; Roya-Kouchaki K; Vergoossen DLE; Fillié-Grijpma Y; Struijk J; Thomas R; Salvatori D; Steyaert C; Blanchetot C; Vanhauwaert R; Silence K; van der Maarel SM; Verschuuren JJ; Huijbers MG Sci Rep; 2023 May; 13(1):7478. PubMed ID: 37156800 [TBL] [Abstract][Full Text] [Related]
17. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors. Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393 [TBL] [Abstract][Full Text] [Related]
18. [Myasthenia gravis induced by autoantibodies against MuSK]. Shigemoto K; Konishi T; Ohta M Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361 [TBL] [Abstract][Full Text] [Related]
19. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584 [TBL] [Abstract][Full Text] [Related]